Gene Therapy Market Size, Share | Industry Trends 2022-28

1. Gene Therapy Market, 2022 - 2028 1

2. Market Overview: The global gene therapy market size was valued at 2,001.4 million in 2021 and is poised to grow at a significant CAGR of 23.4% during the forecast period 2022-28. The gene therapy market research report also provides opportunities for business owners to exploit through the use of relevant approaches. The study’s prospects assist stakeholders and report purchasers in properly planning their investments and augmenting their profits. The report provides a quantitative analysis of the market segments, trends, estimations, and dynamics of the gene therapy market analysis from 2022 to 2028 to identify the prevailing market opportunities. In addition, the report discusses the implications of COVID-19, including the industry's initial response and strategies for ensuring business continuity in the coming years. View Detailed Report Description 2

3. Market Segments: The gene therapy market has been fragmented based on: 1. By Vector Type: Adeno Virus Vector, Adeno-associated Virus Vector, Lentiviral Vector, Retroviral Vector, Herpes Virus Vector, Others. 2. By Disease Type: Oncological Disorders, Cardiovascular Diseases, Lentiviral Vector, Retroviral Vector, Herpes Virus Vector, Others. 3. By Geography: North America, Asia Pacific, Europe, Middle East, and Africa, Latin America Request Sample Report 3

4. Key Players: Some of the major key players in the gene therapy market are: Bristol-Myers Squibb Company Sanofi SA Hoffmann-La Roche Ltd. Novartis AG Shire Plc Gilead Lifesciences, Inc. Request Sample Report 4

5. Europe Office: Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX Asia-Pacific Office: Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad – 500072 Email: sales@precisionbusinessinsights.com Toll-Free: +1-866-598-1553 5